|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 15, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, notes the significance of recent developments with MRI Interventions (MRIC).
MRI Interventions (MRIC) has been gaining traction with investors and medical professionals through the first part of 2012 with the advancement of the ClearPoint and ClearTrace MRI-enhancing technology that has thus far enabled surgeons - by providing real-time imagery during complicated procedures - to conduct less-invasive and more precise operations on the brain and heart, respectively. The technology has proven successful enough in development that Boston Scientific Corporation (BSX) has already invested an up-front payment of $13 million in a partnership with MRIC while Siemens AG (SI) and Brainlab AG have also joined on to advance the technology.
Tuesday morning brought another key development to light when MRIC and Brainlab jointly announced that ClearPoint "is being used in a groundbreaking clinical trial for the treatment of pediatric brain cancer." In conjunction with this announcement, it was revealed that the first procedure had already taken place and the early results were encouraging. A team of professionals gathered at the Memorial Sloan Kettering Cancer Center and "used the ClearPoint System in the delivery of a cancer-fighting agent into the tumor of a pediatric patient while viewing three-dimensional MRI images of the delivery in real-time throughout the procedure."
This is no small milestone for the ClearPoint technology. Medical professionals generally need to be overwhelmingly convinced of a product or drug's safety and efficacy before putting it to use in the pediatric arena. As discussed earlier in the year, the early successes of ClearPoint have gone a long way to gaining the confidence of the medical community.
Full report is available by visiting:
http://vfcsstockhouse.com/blog/article/-mri-interventions-milestone-move-into-pediatric-care-validates-potential
For full list of this week's hot stocks to watch visit: http://vfcsstockhouse.com/blog/article/-weekly-stock-watch-week-of-13-august-amrn-mric-sppi-ssh-imsc-bsx-alth-si-cpst-ttnp-cvm
Contact VFC's Stock House: vfc@vfcsstockhouse.com
Originally published at: http://vfcsstockhouse.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
About VFCsStockHouse.com:
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
